327 related articles for article (PubMed ID: 28708462)
1. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
Wu J; Li B; Sun X; Cao G; Rubin DL; Napel S; Ikeda DM; Kurian AW; Li R
Radiology; 2017 Nov; 285(2):401-413. PubMed ID: 28708462
[TBL] [Abstract][Full Text] [Related]
2. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
[TBL] [Abstract][Full Text] [Related]
4. Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways.
Wu J; Cui Y; Sun X; Cao G; Li B; Ikeda DM; Kurian AW; Li R
Clin Cancer Res; 2017 Jul; 23(13):3334-3342. PubMed ID: 28073839
[No Abstract] [Full Text] [Related]
5. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
[TBL] [Abstract][Full Text] [Related]
6. Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.
van der Velden BHM; Sutton EJ; Carbonaro LA; Pijnappel RM; Morris EA; Gilhuijs KGA
Eur Radiol; 2018 Nov; 28(11):4705-4716. PubMed ID: 29736850
[TBL] [Abstract][Full Text] [Related]
7. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
[TBL] [Abstract][Full Text] [Related]
8. Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study.
Fan M; Cui Y; You C; Liu L; Gu Y; Peng W; Bai Q; Gao X; Li L
Radiology; 2022 Mar; 302(3):516-524. PubMed ID: 34846204
[TBL] [Abstract][Full Text] [Related]
9. MR imaging features associated with distant metastasis-free survival of patients with invasive breast cancer: a case-control study.
Song SE; Shin SU; Moon HG; Ryu HS; Kim K; Moon WK
Breast Cancer Res Treat; 2017 Apr; 162(3):559-569. PubMed ID: 28185146
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.
Cui Y; Tha KK; Terasaka S; Yamaguchi S; Wang J; Kudo K; Xing L; Shirato H; Li R
Radiology; 2016 Feb; 278(2):546-53. PubMed ID: 26348233
[TBL] [Abstract][Full Text] [Related]
11. Imaging Phenotypes of Breast Cancer Heterogeneity in Preoperative Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) Scans Predict 10-Year Recurrence.
Chitalia RD; Rowland J; McDonald ES; Pantalone L; Cohen EA; Gastounioti A; Feldman M; Schnall M; Conant E; Kontos D
Clin Cancer Res; 2020 Feb; 26(4):862-869. PubMed ID: 31732521
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
Yamamoto S; Han W; Kim Y; Du L; Jamshidi N; Huang D; Kim JH; Kuo MD
Radiology; 2015 May; 275(2):384-92. PubMed ID: 25734557
[TBL] [Abstract][Full Text] [Related]
13. Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation.
Wu J; Sun X; Wang J; Cui Y; Kato F; Shirato H; Ikeda DM; Li R
J Magn Reson Imaging; 2017 Oct; 46(4):1017-1027. PubMed ID: 28177554
[TBL] [Abstract][Full Text] [Related]
14. Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
Mazurowski MA; Zhang J; Grimm LJ; Yoon SC; Silber JI
Radiology; 2014 Nov; 273(2):365-72. PubMed ID: 25028781
[TBL] [Abstract][Full Text] [Related]
15. Qualitative Radiogenomics: Association between Oncotype DX Test Recurrence Score and BI-RADS Mammographic and Breast MR Imaging Features.
Woodard GA; Ray KM; Joe BN; Price ER
Radiology; 2018 Jan; 286(1):60-70. PubMed ID: 28885890
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.
Jain R; Poisson LM; Gutman D; Scarpace L; Hwang SN; Holder CA; Wintermark M; Rao A; Colen RR; Kirby J; Freymann J; Jaffe CC; Mikkelsen T; Flanders A
Radiology; 2014 Aug; 272(2):484-93. PubMed ID: 24646147
[TBL] [Abstract][Full Text] [Related]
17. Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer.
van der Velden BH; Dmitriev I; Loo CE; Pijnappel RM; Gilhuijs KG
Radiology; 2015 Sep; 276(3):675-85. PubMed ID: 25811614
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy.
Wu J; Cao G; Sun X; Lee J; Rubin DL; Napel S; Kurian AW; Daniel BL; Li R
Radiology; 2018 Jul; 288(1):26-35. PubMed ID: 29714680
[TBL] [Abstract][Full Text] [Related]
19. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
[TBL] [Abstract][Full Text] [Related]
20. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
